Search

Search Constraints

You searched for: Author/Creator Muto, Yusuke

Search Results

22. Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma. Issue 1 (22nd November 2020)